Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-09-012750
Filing Date
2009-06-30
Accepted
2009-06-30 17:28:34
Documents
1
Period of Report
2009-06-26

Document Format Files

Seq Description Document Type Size
1 p1009684_ex.html 4  
1 p1009684_ex.xml 4 6635
  Complete submission text file 0000919574-09-012750.txt   8889
Mailing Address 1199 MADIA STREET PASADENA CA 91103
Business Address 1199 MADIA STREET PASADENA CA 91103 6267921235
AUTOIMMUNE INC (Issuer) CIK: 0000879106 (see all company filings)

EIN.: 133489062 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LUSMAN CAPITAL MANAGEMENT, LLC 717 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10022
Business Address
LUSMAN JOEL (Reporting) CIK: 0001410669 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20948 | Film No.: 09920036

Mailing Address 717 FIFTH AVENUE 14TH FLOOR NEW YORK NY 10022
Business Address 717 FIFTH AVENUE 14TH FLOOR NEW YORK NY 10022 212-230-4790
LUSMAN CAPITAL MANAGEMENT, LLC (Reporting) CIK: 0001410831 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20948 | Film No.: 09920037